Tuberculosis is a disease caused by the bacterium Mycobacterium tuberculosis. It is spread through the air when a person with M. tuberculosis bacteria in their lungs coughs or speaks. From the lungs, ...

Under the BioVersys and GSK collaboration agreement, AlpE clinical development advances with first patient dosed in Phase 2b trial within UNITE4TB, following completion of a Phase 2a in adults with ...

New Tuberculosis Vaccines: Phase 3 Study Confirms Safety, But It May Not Protect Against All Forms Of Infection The two new tuberculosis vaccines could be safe for use in adults and children in India ...

It has been several years since a new tuberculosis (TB) drug advanced into Phase III trials, but momentum in the field is now picking up, with a vaccine and two novel treatments progressing through ...

The Gates Foundation unveiled plans Wednesday to fund a long-awaited trial for what, if proven effective, would be the first new tuberculosis vaccine in over a century. The 26,000-person, Phase 3 ...

Please provide your email address to receive an email when new articles are posted on . Wellcome and the Gates Foundation will supply up to $550 million for a phase 3 trial of a tuberculosis vaccine, ...

Household contacts of people with tuberculosis (TB) have a high risk of getting TB themselves, at around 2%. It is currently ...

Household contacts of people with tuberculosis (TB) have a high risk of getting TB themselves, at around 2 percent. It is ...

BioVersys AG (SIX: BIOV), a multi-asset, clinical stage biopharmaceutical company focusing on research and development of novel antibacterial products for serious life-threatening infections caused by ...